Great Character.

Mr. Woo Jin Lee is Chief Executive Officer of GC Biopharma USA, bringing more than 26 years of experience in the global healthcare industry. He has held various senior executive management positions throughout his career. Currently, he serves as Senior Vice President of GC Biopharma (formerly known as Green Cross Corporation), one of the leading plasma protein product manufacturers globally. Under his leadership, GC Biopharma's overseas business grew substantially in South America, Eastern Europe, and the Middle East. Mr. Lee's success enabled him to establish key alliances with international organizations worldwide, such as the World Health Organization, UNICEF, and the Pan American Health Organization. Mr. Lee built and grew new operations for GC Biopharma in Brazil, and Vietnam, establishing strategic business centers in both countries.

Mr. Lee has a proven track record with turnkey technology transfer, toll manufacturing, business development, and sales and marketing. He is a determined leader dedicated to delivering top-quality products and services that can improve the lives of many people. Mr. Lee holds a bachelor's degree in genetic engineering from Sungkyunkwan University, South Korea.

Dr. Lisa M. Betts comes to GC Biopharma USA with over 27 years of experience in immunoglobulin therapy. She previously served in senior- and executive-level positions with responsibilities such as sales and operations in several large national healthcare companies. Throughout her career, Dr. Betts has successfully launched new drugs and built programs around them. As the founder and co-owner of Rx Solutions Inc., she created a specialty pharmacy company focused on the clinical management and outcomes of IG in specific chronic disease states. Rx Solutions Inc. grew exponentially and was purchased by Walgreens in 2009.

Since starting her career, she has focused on and been passionate about plasma-based products. Dr. Betts has spoken across the US on plasma therapies and other healthcare topics and is the recipient of numerous professional honors. She attended the College of Pharmacy at University of Illinois at Chicago, where she received her Doctor of Pharmacy degree.

Dr. Alan Huber was educated as a clinical pharmacist with bachelor's degrees in pharmacy and zoology from the University of Maryland, a Doctor of Pharmacy degree from Shenandoah University, and a Master of Business Administration from The George Washington University School of Business. After completing a two-year internship in IV therapy at the National Institutes of Health in Bethesda, Maryland, he has worked in the specialty pharmacy field for the past 20 years, serving in various positions throughout the industry including management roles in both nationally accredited home infusion companies and the plasma pharmaceutical industry.

Dr. Huber has taught immunoglobulin therapy at various pharmacy schools in the US, including as an adjunct assistant professor of pharmacy practice at the University of California School of Pharmacy. Over the years, Dr. Huber has presented widely on the topic of IG therapy at many national conferences.

Mary Longarini comes to GC Biopharma USA with extensive experience in the pharmaceutical industry. She has more than 20 years in senior leadership positions within the plasma industry. Throughout her career, she has led teams and found success with various product launches. Both her plasma industry and commercial start-up experience have been instrumental in building the market access framework for GC Biopharma USA. Mary has received many distinguished honors throughout her pharmaceutical career. She is a graduate of The Pennsylvania State University and a commissioned officer in the United States Army.